NightHawk Biosciences, Inc. (NHWK) Misses Q2 EPS by 34c

NightHawk Biosciences, Inc. (NYSE: NHWK) reported Q2 EPS of ($0.53), $0.34 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $700 thousand versus the consensus estimate of $120 thousand.

For earnings history and earnings-related data on NightHawk Biosciences, Inc. (NHWK) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Hub Group faces credibility test as Q2 report looms Sept. 1
• ONEOK to buy Brazos Midstream Permian assets for $4.43B